How much funding has Resurrect Bio raised?

Resurrect Bio has raised $12.3M in total funding, most recently a Series A round.

Who are Resurrect Bio's investors?

Resurrect Bio's investors include Corteva, SynBioVen, AgFunder.

When was Resurrect Bio founded?

Resurrect Bio was founded in 2021.

Where is Resurrect Bio headquartered?

Resurrect Bio is headquartered in London, United Kingdom.

What industry is Resurrect Bio in?

Resurrect Bio operates in Agtech, Biotech.

How many employees does Resurrect Bio have?

Resurrect Bio has 11-50 employees.

Resurrect Bio

Resurrecting crops' natural disease immunity.

London, United Kingdom · Founded 2021 · $12.3M raised

Agtech

Biotech

Headquarters: London
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: resurrectbio.com
Total Funding: $12.3M
Last Round: $10.3M Series AMay 2026
Rounds: 2

About

Resurrect Bio is a London-based agri-biotech company using AI and high-throughput in-planta screening to discover and resurrect crops' natural immune systems. Founded in 2021 by Cian Duggan, Tolga Osman Bozkurt, and Sophien Kamoun, the company develops disease resistance traits by making precise gene edits that restore plants' natural ability to defend against pathogens — providing a sustainable alternative to chemical crop protection.

Summary

Resurrect Bio is an Agtech company based in London, United Kingdom, founded in 2021. It has raised $12.3M in total across 2 rounds, most recently a $10.3M Series A round in May 2026. Investors include Corteva, SynBioVen and AgFunder.

LinkedIn X (Twitter)